BioAdaptives Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
19.00
3.70
657.90
Cost of Goods Sold (COGS) incl. D&A
-
0.50
0.50
9.70
1.80
-
Gross Income
-
0.50
0.50
9.40
1.90
-
SG&A Expense
18.80
2,435.90
226.70
180.70
64.40
657.90
EBIT
18.80
2,436.40
227.30
171.40
62.50
657.90
Non Operating Income/Expense
0.50
138.30
-
-
-
-
Interest Expense
-
0.70
0.20
-
-
247.90
Pretax Income
18.30
2,575.40
227.40
171.30
62.50
1,406.70
Consolidated Net Income
18.30
2,575.40
227.40
171.30
62.50
1,406.70
Net Income
18.30
2,575.40
227.40
171.30
62.50
1,406.70
Net Income After Extraordinaries
18.30
2,575.40
227.40
171.30
62.50
1,406.70
Net Income Available to Common
18.30
2,575.40
227.40
171.30
62.50
1,406.70
EPS (Basic)
0.00
0.21
0.02
0.01
0.00
0.08
Basic Shares Outstanding
10,569.50
12,474.70
12,726.60
14,002.80
14,525.20
16,973.70
EPS (Diluted)
0.00
0.21
0.02
0.01
0.00
0.08
Diluted Shares Outstanding
10,569.50
12,474.70
12,726.60
14,002.80
14,525.20
16,973.70
EBITDA
18.80
2,435.90
226.80
170.80
62.50
657.90
About BioAdaptives
View Profile
